TrovaGene, Inc. Warrant
TROVW
TROVW was delisted on the 30th of May, 2017.
3 hedge funds and large institutions have $1.81M invested in TrovaGene, Inc. Warrant in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
25% more capital invested
Capital invested by funds: $1.45M → $1.81M (+$360K)
25% less funds holding
Funds holding: 4 → 3 (-1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $9K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$1.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$1K |
| 2 |
Millennium Management
New York
|
-$583 |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$225 |
TROVW Hedge Fund Activity: Q3 2014 in Review
3 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q3 2014, worth a combined $1.81M — up 25% from $1.45M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TROVW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was UBS, adding an estimated $1.22K. The largest seller was Ground Swell Capital, exiting entirely with an estimated $1K sold.
- 3 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q3 2014, down from 4 in Q2 2014.
- Funds reported $1.81M of TrovaGene, Inc. Warrant stock for Q3 2014, up 25% quarter-over-quarter.
- 0 funds opened new TrovaGene, Inc. Warrant positions in Q3 2014 and 1 closed out, a net change of -1 holder.
- The largest TrovaGene, Inc. Warrant buyer in Q3 2014 was UBS, an estimated $1.22K added.
- The largest TrovaGene, Inc. Warrant seller in Q3 2014 was Ground Swell Capital, an estimated $1K sold.
Based on aggregated 13F filings for Q3 2014.